Article Information
History
- May 13, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Colin R. Zamecnik, PhD1,*,
- Jayant V. Rajan, MD, PhD2,*,
- Kevin A. Yamauchi, PhD3,
- Sabrina A. Mann, BS3,4,
- Gavin M. Sowa, MS5,
- Kelsey C. Zorn, MHS4,
- Bonny D. Alvarenga, BA1,
- Mars Stone, PhD6,7,
- Philip J. Norris, MD6,7,8,
- Wei Gu, MD, PhD7,
- Charles Y. Chiu, MD, PhD7,8,
- Joseph L. DeRisi, PhD3,4,** and
- Michael R. Wilson, MD, MAS1,**,***
- 1Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
- 2Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA
- 3Chan Zuckerberg Biohub, San Francisco, CA, USA
- 4Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA
- 5UCSF School of Medicine, San Francisco, CA, USA
- 6Vitalant Research Institute, San Francisco, CA, USA
- 7Department of Laboratory Medicine, University of California, San Francisco, San Francisco, USA
- 8Department of Medicine, University of California, San Francisco, San Francisco, USA
- ↵***Corresponding Author Information: Name: Dr. Michael Wilson, Address: UCSF, Department of Neurology, Division of Neuroimmunology and Glial Biology, 675 Nelson Rising Lane, NS212, Campus Box 3206, San Francisco, CA 94158, Email: michael.wilson{at}ucsf.edu, Phone: 415-502-7429
Posted May 13, 2020.
ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens
